MAGEC2 and breast carcinoma: Second, we co-cultured SUM159PT breast cancer cells (that express the cognate antigen MAGE-C2/HLA-A2) with antigen-specific T cells (CD3+ T lymphocytes transfected with MAGE-C2/HLA-A2 vector).